NCT01218360View on ClinicalTrials.gov

Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Crohn Disease
Interventions
DRUG

Physician standard-of-care

Participants will be treated according to their physician's routine practice and the respective Summary of Product Characteristics (SmPC).

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01218360 - Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484) | Biotech Hunter | Biotech Hunter